SEC Form 4 · accession 0001437749-15-010510
ERBA Diagnostics, Inc. · ERBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernesina Scala
Officer — Chief Financial Officer
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095858
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.06 | May 14, 2015 | A | 40,000 | A | — | May 13, 2025 | Common Stock, par value $0.01 | 40,000 | 40,000 | D |
Explanation of responses
- F1The option becomes exercisable in four equal annual installments on May 14, 2016, 2017, 2018 and 2019.